Contineum Therapeutics, Inc. (CTNM)

Contineum Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	40.89	15.53	5.57	4.63
Short-Term Investments	173.02	109.66	41.67	64.37
Cash & Short-Term Investments	213.91	125.19	47.24	69
Cash Growth	58.31%	165.01%	-31.54%	-
Prepaid Expenses	1.23	2.52	1.15	0.78
Total Current Assets	215.14	127.71	48.39	69.78
Property, Plant & Equipment	0.89	1.4	2.12	0.64
Other Long-Term Assets	0	1.28	0.13	0.1
Total Assets	216.03	130.39	50.64	70.52
Accounts Payable	1.4	0.64	0.43	0.66
Accrued Expenses	3.8	4.39	2.06	1.69
Current Portion of Long-Term Debt	-	-	3.95	1.25
Current Portion of Leases	0.61	0.46	1.11	-
Other Current Liabilities	-	-	-	0.08
Total Current Liabilities	5.81	5.48	7.55	3.67
Long-Term Debt	-	-	-	3.66
Long-Term Leases	-	0.11	0.79	-
Other Long-Term Liabilities	-	0.11	3.03	1.6
Total Liabilities	5.81	5.7	11.37	8.93
Common Stock	0.03	0.01	0.01	0.01
Additional Paid-In Capital	312.48	7.09	4.72	2.74
Retained Earnings	-102.84	-75.14	-97.86	-73.61
Comprehensive Income & Other	0.56	0.11	-0.08	-0.04
Total Common Equity	210.23	-67.94	-93.21	-70.89
Shareholders' Equity	210.23	124.68	39.27	61.59
Total Liabilities & Equity	216.03	130.39	50.64	70.52
Total Debt	0.61	0.57	5.85	4.91
Net Cash (Debt)	213.3	124.62	41.39	64.1
Net Cash Growth	59.17%	201.08%	-35.42%	-
Net Cash Per Share	15.83	36.70	18.45	30.39
Filing Date Shares Outstanding	25.78	2.35	2.26	2.11
Total Common Shares Outstanding	25.74	2.35	2.26	2.11
Working Capital	209.34	122.22	40.84	66.11
Book Value Per Share	8.17	-28.91	-41.25	-33.61
Tangible Book Value	210.23	-67.94	-93.21	-70.89
Tangible Book Value Per Share	8.17	-28.91	-41.25	-33.61
Machinery	-	2.11	1.69	1.58
Leasehold Improvements	-	0.05	0.02	0.02

Source: S&P Capital IQ. Standard template. Financial Sources.